Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

TBE Zone 0/1 PMS in Japan

NCT: NCT07691931 · NOT_YET_RECRUITING

NCT IDNCT07691931
StatusNOT_YET_RECRUITING
Start Date2026-09
Completion2035-09
SponsorW.L.Gore & Associates (INDUSTRY)
First posted
Last updated

Brief Summary

The goal of this surveillance is to confirm the safety and efficacy of TBE under actual use in the Zone 0/1 lesion on post-marketing usage conditions.

Frequently Asked Questions

What is TBE Zone 0/1 PMS in Japan?

TBE Zone 0/1 PMS in Japan is a clinical trial registered under NCT07691931. Current status: NOT_YET_RECRUITING.

What is the status of NCT07691931?

The current status of NCT07691931 (TBE Zone 0/1 PMS in Japan) is: NOT_YET_RECRUITING.

When did TBE Zone 0/1 PMS in Japan start?

TBE Zone 0/1 PMS in Japan started on 2026-09.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.

↑